Clinical Trials Sponsored by Vion Pharmaceuticals

Total 19760 results

Viron Therapeutics Inc
Vion Pharmaceuticals

Terminated

Treatment of Elderly Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic (MD) Syndrome With Laromustine and Infusional Cytarabine

Acute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)

United States
Northwestern University
Vion Pharmaceuticals

Terminated

VNP40101M and Temozolomide in Treating Patients With Progressive or Relapsed Malignant Glioma

Brain and Central Nervous System Tumors

United States
Vion Pharmaceuticals

Unknown

VNP40101M Followed by Cytarabine in Treating Older Patients With Acute Myeloid Leukemia

Leukemia

France, United States, United Kingdom
Vion Pharmaceuticals

Completed

VNP40101M in Treating Patients With Relapsed or Refractory Locally Advanced or Metastatic Small Cell Lung Cancer

Lung Cancer

United States
Vion Pharmaceuticals

Completed

Temozolomide and VNP40101M in Treating Patients With Relapsed or Refractory Leukemias

Leukemia

United States
Vion Pharmaceuticals

Completed

VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome

Myelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative Neoplasms

United States
Vion Pharmaceuticals

Completed

3-AP and Cytarabine in Treating Patients With Hematologic Cancer

Myelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative Neoplasms

United States
Vion Pharmaceuticals

Completed

3-AP in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Vion Pharmaceuticals

Completed

VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia

Myelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative Neoplasms

United States, France, United Kingdom
M.D. Anderson Cancer Center
Vion Pharmaceuticals

Completed

Cloretazine (VNP40101M) With Hematopoietic Cell Transplantation for Hematologic Malignancies

Hematologic Malignancies

United States
Vion Pharmaceuticals

Completed

3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung Cancer

Lung Cancer

United States, Netherlands
Vion Pharmaceuticals

Completed

VNP40101M in Treating Patients With Richter Syndrome or Refractory or Relapsed Chronic Lymphocytic Leukemia or Other Lymphoproliferative Disorders

Lymphoma | Leukemia

United States
Vion Pharmaceuticals

Completed

VNP20009 in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Vion Pharmaceuticals

Completed

VNP40101M in Treating Patients With Advanced Solid Tumors or Lymphomas

Lymphoma | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol Specific

United States
Vion Pharmaceuticals

Completed

3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone in Treating Patients With Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Vion Pharmaceuticals
National Cancer Institute (NCI)

Completed

VNP40101M and Cytarabine in Treating Patients With Hematologic Malignancies

Myelodysplastic Syndromes | Leukemia

United States
Vion Pharmaceuticals

Completed

3-AP in Treating Patients With Advanced Prostate Cancer

Prostate Cancer

United States
Vion Pharmaceuticals

Completed

Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia

Leukemia

France, Canada, Greece, United States, Belgium, Netherlands, United Kingdom, Germany, Poland, Serbia
Vion Pharmaceuticals

Completed

3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer

Pancreatic Cancer

United States, United Kingdom, Belgium
Vion Pharmaceuticals

Completed

Combination Chemotherapy in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Vion Pharmaceuticals

Completed

3-AP Plus Cisplatin and Paclitaxel in Treating Patients With Advanced or Metastatic Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Vion Pharmaceuticals

Completed

VNP40101M in Treating Patients With Advanced or Metastatic Cancer

Lymphoma | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol Specific

United States
Vion Pharmaceuticals

Completed

VNP20009 in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Therapy

Unspecified Adult Solid Tumor, Protocol Specific

United States
Sion Microtec Ltd.

Unknown

Safety and Efficacy Study Comparing Pad-gauze With Anti-fibrinolytic Agent Hemostopan™) to a Regular Pad-gauze

Bleeding | Coagulopathy

Israel
Viron Therapeutics Inc

Terminated

Serp-1 for the Treatment of Acute Coronary Syndrome

Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis

United States, Canada
Rion Inc.
ProPharma

Active, not recruiting

PEP on a Skin Graft Donor Site Wound

Skin Graft

United States
Novartis Pharmaceuticals
Chugai Pharmaceutical

Completed

Study of Safety and Efficacy of Letrozole Monotherapy as Second-line Endocrine Therapy in Postmenopausal Patients With Advanced Breast Cancer Who Received Previous Anti-estrogen Treatment

Postmenopausal Women With Advanced Breast Cancer

Japan
Novartis Pharmaceuticals
Chugai Pharmaceutical

Completed

Extension Study of 1.0mg Dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer

Postmenopausal Women With Advanced Breast Cancer

Japan
Novartis Pharmaceuticals
Chugai Pharmaceutical

Completed

Study of High-dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer

Postmenopausal Women With Advanced Breast Cancer

Japan
Bnai Zion Medical Center

Recruiting

Naturopathic-pharmacological Consultation in Hematology

Hematologic Diseases

Israel
Bnai Zion Medical Center

Recruiting

Integrative Medicine in Lymphoma Survivors

Lymphoma

Israel
Bnai Zion Medical Center

Recruiting

Delirium Detection During Routine Patient Care

Delirium

Israel
Bnai Zion Medical Center

Recruiting

The Incidents of Weekend Headaches in Children

Headache | Child, Only

Israel
Bnai Zion Medical Center

Not yet recruiting

Comparison of the Clinical Performances of Air-Q SP 3G and i-Gel

Anesthesia
Lion TCR Pte. Ltd.

Recruiting

Redirected HBV-Specific T Cells in Patients With HBV-related HCC (SAFE-T-HBV) (SAFE-T-HBV)

Hepatocellular Carcinoma

Singapore
Bnai Zion Medical Center

Not yet recruiting

A Comparison of Fiberoptic Endotracheal Intubation Between the Intubating Laryngeal Tube Suction and the LMA Protector

Difficult Airway
Bnai Zion Medical Center

Terminated

Labor Induction With Double Balloon Device, Oral Misoprostol and Concomitant Use of Both (IDOM)

Pregnancy Related

Israel
Bnai Zion Medical Center

Completed

The Impact of nCoV-2019 on Children With Migraine

Migraine Disorders | COVID-19 Pandemic

Israel
Bnai Zion Medical Center

Completed

A Comparison Between the Intubating Laryngeal Tube Suction and the Ambu AuraGain

Difficult Intubation

Israel
Bnai Zion Medical Center

Unknown

Cervical Ripening With the Double Balloon Device for 6 Hours Compared With 12 Hours (DoubleCRIB)

Induction of Labor | Unfavorable Cervix

Israel
Bnai Zion Medical Center

Completed

Cortisol Response to Low Dose Cosyntropin Stimulation Test in the Late Afternoon

Adrenal Insufficiency

Israel
Bnai Zion Medical Center

Unknown

Combined Acoustic and Electric Hearing (CI/HA) in Adult Bimodal Users Using a HA With a Bimodal Fitting Formula

Hearing Loss
Bnai Zion Medical Center

Unknown

The Effect of Combined General-epidural vs General Anaesthesia on Postoperative Gastrointestinal Surgery

Infant, Newborn, Diseases | Infection | Epidural Anesthesia
Bnai Zion Medical Center

Unknown

A Comparison of Direct Laryngoscopy With Blind Intubation Via Intubating Laryngeal Tube Suction Disposable

Adverse Anesthesia Outcome
Bnai Zion Medical Center

Completed

Standardized 1µg Adrenocorticotropic Hormone Stimulation Test, and Salivary Cortisol Concentration During the Test

Healthy

Israel
Bnai Zion Medical Center

Unknown

Comparison of Direct Laryngoscopy With Blind Intubation Via Intubating Laryngeal Mask Airway

Adverse Anesthesia Outcome
Bnai Zion Medical Center

Unknown

A Comparison Between the Intubating Laryngeal Tube Suction and the Ambu AuraGain

Intubation; Difficult
Bnai Zion Medical Center

Completed

Comparison Between the Supreme Laryngeal Mask Airway and the Laryngeal Tube Suction During Spontaneous Ventilation

Adverse Anesthesia Outcome

Israel
Bnai Zion Medical Center

Unknown

The New Laryngeal Tube Suction-Disposable for Childrens

Adverse Anesthesia Outcome
Bnai Zion Medical Center

Completed

Pregnancy Outcome in Woman With Threatened Abortion (POTA)

Threatened Abortion

Clinical Trials Sponsored by Vion Pharmaceuticals

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations